| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 1.63e-05 | 2 | 81 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 1.61e-04 | 5 | 81 | 2 | GO:0097109 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 4.07e-07 | 16 | 82 | 4 | GO:0007158 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 2.38e-05 | 86 | 82 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 2.80e-05 | 89 | 82 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | organelle assembly | WDR19 RAB19 NRAP MYOM1 NRXN1 NRXN2 PWP2 MYOM3 MYOM2 CEP126 GDI2 CDKL1 CNOT2 PGM5 JHY | 3.72e-05 | 1138 | 82 | 15 | GO:0070925 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 4.67e-05 | 239 | 82 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 9.32e-05 | 4 | 82 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 1.55e-04 | 5 | 82 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | extraocular skeletal muscle development | 1.55e-04 | 5 | 82 | 2 | GO:0002074 | |
| GeneOntologyCellularComponent | M band | 2.42e-04 | 31 | 82 | 3 | GO:0031430 | |
| GeneOntologyCellularComponent | azurophil granule lumen | 4.54e-04 | 91 | 82 | 4 | GO:0035578 | |
| GeneOntologyCellularComponent | vacuolar lumen | 6.80e-04 | 178 | 82 | 5 | GO:0005775 | |
| GeneOntologyCellularComponent | actin-based cell projection | 7.88e-04 | 278 | 82 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.81e-04 | 290 | 82 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | A band | 1.12e-03 | 52 | 82 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | lysosome | CBLIF RNF167 ATP6AP1 MAN2B1 OSTM1 SERPINB3 CTSC CFTR MITF GDI2 | 1.25e-03 | 811 | 82 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | CBLIF RNF167 ATP6AP1 MAN2B1 OSTM1 SERPINB3 CTSC CFTR MITF GDI2 | 1.25e-03 | 811 | 82 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | neuronal cell body | 1.56e-03 | 835 | 82 | 10 | GO:0043025 | |
| GeneOntologyCellularComponent | secretory granule lumen | 1.75e-03 | 325 | 82 | 6 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.89e-03 | 330 | 82 | 6 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.95e-03 | 332 | 82 | 6 | GO:0031983 | |
| Domain | RabGDI | 1.90e-05 | 2 | 82 | 2 | IPR000806 | |
| Domain | IGc2 | 7.79e-05 | 235 | 82 | 7 | SM00408 | |
| Domain | Ig_sub2 | 7.79e-05 | 235 | 82 | 7 | IPR003598 | |
| Domain | GDI | 1.14e-04 | 4 | 82 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 1.14e-04 | 4 | 82 | 2 | IPR018203 | |
| Domain | GATase | 1.89e-04 | 5 | 82 | 2 | PF00117 | |
| Domain | Ig_I-set | 1.89e-04 | 190 | 82 | 6 | IPR013098 | |
| Domain | I-set | 1.89e-04 | 190 | 82 | 6 | PF07679 | |
| Domain | GATASE | 2.82e-04 | 6 | 82 | 2 | IPR017926 | |
| Domain | GATASE_TYPE_1 | 2.82e-04 | 6 | 82 | 2 | PS51273 | |
| Domain | Syndecan | 3.94e-04 | 7 | 82 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 3.94e-04 | 7 | 82 | 2 | IPR027789 | |
| Domain | IG | 5.18e-04 | 421 | 82 | 8 | SM00409 | |
| Domain | Ig_sub | 5.18e-04 | 421 | 82 | 8 | IPR003599 | |
| Domain | LAM_G_DOMAIN | 6.16e-04 | 38 | 82 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 7.17e-04 | 40 | 82 | 3 | PF02210 | |
| Domain | - | 8.38e-04 | 10 | 82 | 2 | 3.40.50.880 | |
| Domain | LamG | 9.49e-04 | 44 | 82 | 3 | SM00282 | |
| Domain | Class_I_gatase-like | 1.22e-03 | 12 | 82 | 2 | IPR029062 | |
| Domain | IG_LIKE | 1.40e-03 | 491 | 82 | 8 | PS50835 | |
| Domain | Ig-like_dom | 1.63e-03 | 503 | 82 | 8 | IPR007110 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.63e-03 | 53 | 82 | 3 | IPR011047 | |
| Domain | Neurexin-like | 1.67e-03 | 14 | 82 | 2 | IPR003585 | |
| Domain | 4.1m | 1.67e-03 | 14 | 82 | 2 | SM00294 | |
| Domain | FN3 | 1.83e-03 | 199 | 82 | 5 | PS50853 | |
| Domain | Laminin_G | 2.12e-03 | 58 | 82 | 3 | IPR001791 | |
| Domain | FN3_dom | 2.27e-03 | 209 | 82 | 5 | IPR003961 | |
| Domain | IGv | 4.39e-03 | 75 | 82 | 3 | SM00406 | |
| Domain | PAS | 5.35e-03 | 25 | 82 | 2 | PF00989 | |
| Domain | PAS_fold | 5.35e-03 | 25 | 82 | 2 | IPR013767 | |
| Domain | fn3 | 5.65e-03 | 162 | 82 | 4 | PF00041 | |
| Domain | - | 8.45e-03 | 95 | 82 | 3 | 2.60.120.200 | |
| Domain | - | 8.57e-03 | 663 | 82 | 8 | 2.60.40.10 | |
| Domain | PAS | 8.67e-03 | 32 | 82 | 2 | SM00091 | |
| Pubmed | Myomesin 3, a novel structural component of the M-band in striated muscle. | 1.31e-07 | 5 | 83 | 3 | 18177667 | |
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 7.28e-07 | 8 | 83 | 3 | 20215401 | |
| Pubmed | 1.18e-06 | 225 | 83 | 7 | 12168954 | ||
| Pubmed | 2.98e-06 | 497 | 83 | 9 | 23414517 | ||
| Pubmed | Bone growth: a study of the grey-lethal and microphthalmic mutants of the mouse. | 5.63e-06 | 2 | 83 | 2 | 13162938 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30709877 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 1198094 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27527752 | ||
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 5.63e-06 | 2 | 83 | 2 | 1621094 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7585614 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26595880 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK5R1 FAT1 MAN2B1 KALRN CDK12 PIK3CD UBR4 MYOM3 GEMIN5 MLLT10 TIAM2 IGSF3 | 1.21e-05 | 1105 | 83 | 12 | 35748872 |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 1.69e-05 | 3 | 83 | 2 | 34133920 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38891114 | ||
| Pubmed | FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy. | 1.69e-05 | 3 | 83 | 2 | 26025865 | |
| Pubmed | The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. | 1.69e-05 | 3 | 83 | 2 | 19465887 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26240314 | ||
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 1.69e-05 | 3 | 83 | 2 | 21424692 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 25769544 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30858964 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28013231 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 16406382 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7543319 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 1.69e-05 | 3 | 83 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 1.69e-05 | 3 | 83 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 1.69e-05 | 3 | 83 | 2 | 29045040 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31005376 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 38571813 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 35173587 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17105730 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7513052 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 22562206 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11551916 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 1.69e-05 | 3 | 83 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 1.69e-05 | 3 | 83 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 1.69e-05 | 3 | 83 | 2 | 11944992 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 1.69e-05 | 3 | 83 | 2 | 17035546 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 1.69e-05 | 3 | 83 | 2 | 25423136 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7505783 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.90e-05 | 344 | 83 | 7 | 30333137 | |
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 3.37e-05 | 4 | 83 | 2 | 14983056 | |
| Pubmed | Characteristics of the mouse genomic histamine H1 receptor gene. | 3.37e-05 | 4 | 83 | 2 | 8812432 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 32706374 | ||
| Pubmed | p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression. | 3.37e-05 | 4 | 83 | 2 | 22422878 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 12972258 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 35857633 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10438587 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 8786425 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 3.37e-05 | 4 | 83 | 2 | 32134527 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 7629107 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 3.37e-05 | 4 | 83 | 2 | 33888718 | |
| Pubmed | 3.95e-05 | 529 | 83 | 8 | 14621295 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.95e-05 | 400 | 83 | 7 | 35013556 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 28472659 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 36709330 | ||
| Pubmed | Localization of the synapsin II (SYN2) gene to human chromosome 3 and mouse chromosome 6. | 5.60e-05 | 5 | 83 | 2 | 8530057 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 22833560 | ||
| Pubmed | GDI-1 preferably interacts with Rab10 in insulin-stimulated GLUT4 translocation. | 5.60e-05 | 5 | 83 | 2 | 19570034 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.60e-05 | 5 | 83 | 2 | 18923512 | |
| Pubmed | Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport. | 5.60e-05 | 5 | 83 | 2 | 11929610 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 9223334 | ||
| Pubmed | GMPS BPHL NRXN1 KALRN UBR4 ERBIN CNOT2 PDXK IGSF3 SACM1L PHACTR1 | 8.28e-05 | 1139 | 83 | 11 | 36417873 | |
| Pubmed | Establishment of cardiac cytoarchitecture in the developing mouse heart. | 8.39e-05 | 6 | 83 | 2 | 16337936 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 23183047 | ||
| Pubmed | Neurexin-Neuroligin Synaptic Complex Regulates Schizophrenia-Related DISC1/Kal-7/Rac1 "Signalosome". | 8.39e-05 | 6 | 83 | 2 | 26078884 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 8.39e-05 | 6 | 83 | 2 | 12827191 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 8281148 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 8.39e-05 | 6 | 83 | 2 | 8576240 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 30683685 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 11809807 | ||
| Pubmed | RNF167 CDK5R1 NRXN2 FZD3 ZNF429 DYNLT1 OGA ERBIN PDXK PHACTR1 | 1.41e-04 | 1006 | 83 | 10 | 15226823 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAB19 FAT1 ATP6AP1 KALRN CDHR2 SERPINB3 CTSC GDI2 TIAM2 PDXK | 1.53e-04 | 1016 | 83 | 10 | 19056867 |
| Pubmed | 1.55e-04 | 335 | 83 | 6 | 15741177 | ||
| Pubmed | Transcriptional organization of a 450-kb region of the human X chromosome in Xq28. | 1.56e-04 | 8 | 83 | 2 | 8248200 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 1.56e-04 | 8 | 83 | 2 | 30871858 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 37591863 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 21356198 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 34919427 | ||
| Pubmed | 2.00e-04 | 9 | 83 | 2 | 9707552 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.07e-04 | 857 | 83 | 9 | 25609649 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.31e-04 | 361 | 83 | 6 | 26167880 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 7588749 | ||
| Pubmed | Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. | 2.50e-04 | 10 | 83 | 2 | 20659789 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 2.50e-04 | 10 | 83 | 2 | 20368620 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 3.00e-04 | 536 | 83 | 7 | 15840001 | |
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 24925909 | ||
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 32973045 | ||
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 21949878 | ||
| Pubmed | 3.07e-04 | 538 | 83 | 7 | 10512203 | ||
| Pubmed | GMPS TRAPPC13 ARNT SERPINB3 UBR4 QRICH1 OGA GDI1 CNOT2 USP19 SACM1L | 3.12e-04 | 1327 | 83 | 11 | 32694731 | |
| Pubmed | 3.45e-04 | 251 | 83 | 5 | 27507650 | ||
| Pubmed | Planar cell polarity genes control the connectivity of enteric neurons. | 3.66e-04 | 12 | 83 | 2 | 23478408 | |
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 3.66e-04 | 12 | 83 | 2 | 8618961 | |
| Pubmed | 4.85e-04 | 963 | 83 | 9 | 28671696 | ||
| Cytoband | 5q12.3 | 4.85e-04 | 18 | 83 | 2 | 5q12.3 | |
| Cytoband | 22q12.1 | 1.55e-03 | 32 | 83 | 2 | 22q12.1 | |
| Cytoband | 11q24.1 | 2.06e-03 | 37 | 83 | 2 | 11q24.1 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.83e-06 | 8 | 59 | 3 | 658 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.39e-05 | 161 | 59 | 6 | 593 | |
| GeneFamily | Cadherin related | 2.17e-05 | 17 | 59 | 3 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 1.74e-04 | 160 | 59 | 5 | 555 | |
| GeneFamily | Cyclin dependent kinases | 3.24e-03 | 26 | 59 | 2 | 496 | |
| GeneFamily | Immunoglobulin like domain containing | 3.62e-03 | 193 | 59 | 4 | 594 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 3.58e-05 | 194 | 83 | 6 | M2517 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 3.91e-05 | 519 | 83 | 9 | M3395 | |
| Coexpression | GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 4.01e-05 | 198 | 83 | 6 | M4249 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 4.12e-05 | 199 | 83 | 6 | M4444 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 4.24e-05 | 200 | 83 | 6 | M7518 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 5.55e-05 | 543 | 83 | 9 | MM997 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 5.56e-05 | 210 | 83 | 6 | MM958 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.09e-09 | 194 | 83 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.63e-09 | 198 | 83 | 8 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.31e-08 | 188 | 83 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.04e-08 | 191 | 83 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.83e-08 | 194 | 83 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.99e-08 | 198 | 83 | 7 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.03e-06 | 178 | 83 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 184 | 83 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.25e-06 | 184 | 83 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.29e-06 | 185 | 83 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.42e-06 | 188 | 83 | 6 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 190 | 83 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.60e-06 | 192 | 83 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.76e-06 | 195 | 83 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.76e-06 | 195 | 83 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-06 | 122 | 83 | 5 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-05 | 166 | 83 | 5 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 170 | 83 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | FLU-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 1.81e-05 | 173 | 83 | 5 | 8c218ec1ba927e9312f3df5f312395e907ab64ab | |
| ToppCell | FLU-Healthy-5|FLU / Virus stimulation, Condition and Cluster | 1.81e-05 | 173 | 83 | 5 | bd4f06d971f9d138749094047c9337dfbaf5da31 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 1.81e-05 | 173 | 83 | 5 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.02e-05 | 177 | 83 | 5 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 181 | 83 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 181 | 83 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.37e-05 | 183 | 83 | 5 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.37e-05 | 183 | 83 | 5 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 184 | 83 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.49e-05 | 185 | 83 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.69e-05 | 188 | 83 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.76e-05 | 189 | 83 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.76e-05 | 189 | 83 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.83e-05 | 190 | 83 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.83e-05 | 190 | 83 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.83e-05 | 190 | 83 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.90e-05 | 191 | 83 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.05e-05 | 193 | 83 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-05 | 195 | 83 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 3.29e-05 | 196 | 83 | 5 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-05 | 196 | 83 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.45e-05 | 198 | 83 | 5 | 32d58379a89be19b6b1a494bf033416546771c19 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-Neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-05 | 199 | 83 | 5 | ae575ed7582f2a4218f6cbcbf5f7f0ce7a5bc26b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Control-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 7.52e-05 | 120 | 83 | 4 | 840d0ac995e2fa41996514753e4e03c4aa4a26d0 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.33e-04 | 139 | 83 | 4 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.60e-04 | 146 | 83 | 4 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-04 | 147 | 83 | 4 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.73e-04 | 149 | 83 | 4 | 92a8931a51db619fb5f0638d319c02e7838f6559 | |
| ToppCell | ASK452-Epithelial-Type_2|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.07e-04 | 156 | 83 | 4 | e2b8d65c38cedb8ec6c3c1b138957145af931c51 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 158 | 83 | 4 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.27e-04 | 160 | 83 | 4 | 70f3637dd0bcfcef421aa114f946fff0048f192e | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-04 | 162 | 83 | 4 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 163 | 83 | 4 | 22fa5d017ff796394394d952ec151e2d1beb8248 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.62e-04 | 166 | 83 | 4 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 169 | 83 | 4 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 169 | 83 | 4 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 169 | 83 | 4 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 170 | 83 | 4 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 170 | 83 | 4 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 170 | 83 | 4 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.06e-04 | 173 | 83 | 4 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.06e-04 | 173 | 83 | 4 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-04 | 174 | 83 | 4 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.13e-04 | 174 | 83 | 4 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-04 | 174 | 83 | 4 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 175 | 83 | 4 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 175 | 83 | 4 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-04 | 176 | 83 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 176 | 83 | 4 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 178 | 83 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.48e-04 | 179 | 83 | 4 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | CD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.48e-04 | 179 | 83 | 4 | 7f18dffa85285599662edbcd3f32ab42672bffb8 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.48e-04 | 179 | 83 | 4 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 3.56e-04 | 180 | 83 | 4 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 3.63e-04 | 181 | 83 | 4 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-04 | 182 | 83 | 4 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 183 | 83 | 4 | 905e1e9be0f15be184447df04b134a6aa8279074 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 183 | 83 | 4 | 92eed783347a372b850de3189e72525082390014 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 183 | 83 | 4 | 0d21befacefc6c597e7b501ed41b7fe9385a78df | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 3.79e-04 | 183 | 83 | 4 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 3.87e-04 | 184 | 83 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 184 | 83 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 185 | 83 | 4 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 3.95e-04 | 185 | 83 | 4 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.95e-04 | 185 | 83 | 4 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.95e-04 | 185 | 83 | 4 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 186 | 83 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-04 | 186 | 83 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.03e-04 | 186 | 83 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 186 | 83 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-04 | 187 | 83 | 4 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.11e-06 | 181 | 82 | 7 | 1077_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 2559_DN | |
| Disease | breast cancer, ovarian carcinoma | 3.09e-06 | 37 | 80 | 4 | EFO_0001075, MONDO_0007254 | |
| Disease | urinary pH measurement | 7.22e-05 | 5 | 80 | 2 | EFO_0010136 | |
| Disease | urinary albumin to creatinine ratio | 1.29e-04 | 179 | 80 | 5 | EFO_0007778 | |
| Disease | handedness | 2.02e-04 | 106 | 80 | 4 | EFO_0009902 | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.31e-04 | 54 | 80 | 3 | EFO_0004792 | |
| Disease | melanoma | 5.80e-04 | 248 | 80 | 5 | C0025202 | |
| Disease | thalamus volume change measurement | 6.47e-04 | 14 | 80 | 2 | EFO_0021496 | |
| Disease | Alzheimer disease, Cognitive impairment | 7.45e-04 | 15 | 80 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | cancer (implicated_via_orthology) | 8.22e-04 | 268 | 80 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 8.47e-04 | 68 | 80 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | serine measurement, amino acid measurement | 9.61e-04 | 17 | 80 | 2 | EFO_0005134, EFO_0009774 | |
| Disease | Lymphoma, Follicular | 1.34e-03 | 20 | 80 | 2 | C0024301 | |
| Disease | coronary artery disease | 1.43e-03 | 1194 | 80 | 10 | EFO_0001645 | |
| Disease | Bronchiectasis | 1.62e-03 | 22 | 80 | 2 | C0006267 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.77e-03 | 23 | 80 | 2 | C1708353 | |
| Disease | pain | 2.01e-03 | 196 | 80 | 4 | EFO_0003843 | |
| Disease | gout | 2.01e-03 | 196 | 80 | 4 | EFO_0004274 | |
| Disease | FEV change measurement, response to zileuton | 2.09e-03 | 25 | 80 | 2 | EFO_0005921, EFO_0007676 | |
| Disease | Squamous cell carcinoma of esophagus | 2.22e-03 | 95 | 80 | 3 | C0279626 | |
| Disease | red blood cell density measurement | 2.65e-03 | 880 | 80 | 8 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNNIHTYQGKTLQGT | 116 | A8MT66 | |
| TSSVGREQVNKAYHA | 81 | Q9H6S1 | |
| YHNINADQSKGISSS | 561 | P27540 | |
| GQQNYSSATLSHKDV | 1231 | Q96RT1 | |
| SNTKNYTGESQAKHV | 226 | Q8IWD4 | |
| SSNSVVHAETKLQNY | 1426 | Q9NYV4 | |
| AATVGHYTAVQNSKN | 21 | Q15078 | |
| DKGNSTHSRNNSYAV | 891 | P13569 | |
| SVSVNYGDQVQHFKV | 96 | Q13588 | |
| KGATLSHYNIVNNSN | 271 | Q96CM8 | |
| HFKSGVYTETQQNTI | 36 | A4D1S5 | |
| AVAGTYQNTAQTVHI | 401 | Q2TAL8 | |
| HKVTKVSNVYSQTNG | 561 | Q96NI6 | |
| GQQFAVGSHVYSVAK | 461 | Q15124 | |
| VTVQENSAAKTYVGH | 41 | Q14517 | |
| YISNSAQSNGAVVKE | 436 | P58400 | |
| HNVAAQGKYIAIVST | 341 | P50395 | |
| SQFVYHINTHGSTKN | 511 | Q6NUN7 | |
| QSGVAYKAGNEQSVH | 746 | Q86VF7 | |
| LSGNEYVFTKNVHQS | 516 | O95263 | |
| AGHYASQQIKQISTQ | 381 | O60229 | |
| YISNSAQSNGAVVKE | 1676 | Q9P2S2 | |
| GVHNDVSKFNTQNYA | 521 | P48552 | |
| YISNSAQSNGAVVKE | 1441 | Q9ULB1 | |
| GNAHSLLQTKNYSEV | 206 | Q86WC4 | |
| QYKIAANQASVISHQ | 386 | Q14541 | |
| TASFSAQQHKGSLQV | 1016 | Q5TIA1 | |
| NNTGYINASHIKVSV | 946 | Q16825 | |
| YTAQKSGQQGVAQHH | 261 | Q9C0D0 | |
| TNKQAFITAQNHGYA | 326 | P31327 | |
| FSVAANGSVYINQSK | 866 | Q9BYE9 | |
| QNVAVQDSGTYSCHV | 906 | O75054 | |
| SSINNIAENVNHKTY | 371 | P27352 | |
| GIQVKVINAAHSFYN | 291 | P49915 | |
| HQQVFSTNQYFSGVK | 226 | Q00532 | |
| LSNVTSNYDFVGQHK | 546 | Q9P2H0 | |
| GTYTTNKTKNNHVSD | 1296 | O75417 | |
| ESAIGGNAYQHSKVN | 26 | P63172 | |
| KVGTASENVYVNIAH | 141 | P53634 | |
| HGAITNTKVQYRVSA | 681 | P41182 | |
| AQQAKGSSVHVLYST | 341 | O00754 | |
| SIQATIQNVHSAKDY | 336 | Q6UXX5 | |
| QYKASTVTQGSHNKA | 271 | Q9NPG1 | |
| NIADSNGNTALHYSV | 661 | Q63ZY3 | |
| HNVAAQGKYIAIAST | 341 | P31150 | |
| YIHSNQNVIGSSKAE | 1131 | Q5T890 | |
| SAKVAVNGVQLHYQQ | 41 | Q86WA6 | |
| QAQAASEIAVGHQYK | 131 | Q3KQZ1 | |
| EQIVHYNGSKASFVQ | 241 | Q9NTJ5 | |
| QETQAAAHNYATKQS | 111 | A0A1W2PPM1 | |
| AAHNYATKQSLSGAQ | 116 | A0A1W2PPM1 | |
| AYGKLSFHQTQVSQR | 301 | Q969Z0 | |
| HTFTVNAASGEQYKL | 121 | Q9BXB4 | |
| AGVISFYNVTNKSHI | 366 | Q96PL5 | |
| ASGTSAGVHVYNVKQ | 501 | Q969X6 | |
| KSSHFYSNVGLQIQT | 81 | Q6ZU15 | |
| QFIDYGNVSVVHTNK | 1386 | O60522 | |
| QYSSRQVAHSGAKAS | 396 | O60502 | |
| AQKAGYGAAVVHNVN | 101 | Q9H6Y7 | |
| SKDGNYSVHQNSHTR | 41 | A0A1B0GTD5 | |
| QTQSGKVNNIYLSTH | 621 | Q8NEZ3 | |
| QVTENTTGKAATYHV | 61 | P29508 | |
| DAVNSVQFSNHTGYA | 36 | O00764 | |
| NANFQEVSAHTSSGK | 291 | P55197 | |
| NEGNQKVVITYSSRH | 56 | Q9H6B4 | |
| IQKNTQAAHDGSGIY | 401 | Q7LGC8 | |
| GHTLSEKRNYQVTNS | 6 | Q9NZN8 | |
| SKASQFTGYAQHDAQ | 576 | O94966 | |
| VSKYGSQFQGNSQHD | 171 | Q70EL4 | |
| SQYTLQGSKNHSNTI | 6 | Q8IVF5 | |
| QYLSTTLANKHANQV | 141 | O75030 | |
| QSESYVLKQQGHFNS | 361 | Q15269 | |
| ASGSNNAVIYVHNLK | 601 | Q8TEQ6 | |
| YDFVHVIQQGKTNNS | 936 | O00329 | |
| EVHSNGSVAYFNASQ | 346 | Q15904 | |
| QAFSGINVQYKLHSS | 431 | P07949 | |
| FSNSNTYKTRHTGIN | 156 | O75346 | |
| ASQASTHGNLAVAYQ | 551 | Q96AY4 | |
| HYSGVSQNIRSKAQI | 241 | Q86YA3 | |
| NQSSALTNHKRIYVG | 211 | Q86V71 | |
| YGSSTNLKDHQVSNT | 801 | Q96JM2 | |
| SSYISVHNDSNQVVK | 81 | A5PLN9 | |
| VYNAQQIKHRLNSTG | 2311 | Q5T4S7 | |
| VNSKTVTEASGHKYN | 151 | Q96RE9 | |
| YTFQLQDGKATNHST | 1316 | P52179 | |
| ATNAHGQVSTNAAVV | 231 | P54296 | |
| ATYTVRVKNAHGQAS | 226 | Q5VTT5 |